To include your compound in the COVID-19 Resource Center, submit it here.

Venture import play

3SBio launches Chinese government-supported VC fund to build out pipeline

3SBio Inc. (NASDAQ:SSRX) is forming 3SBio Ventures, a Chinese government-supported entity that will make strategic investments in small to mid-sized U.S. life science plays. In exchange for equity, 3SBio hopes to obtain Chinese licensing rights to biologics for oncology, nephrology and inflammatory diseases.

One of the most important features of the fund,

Read the full 514 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers